Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ. (Q39121775)
Jump to navigation
Jump to search
scientific article published on 21 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ. |
scientific article published on 21 July 2013 |
Statements
1 reference
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ. (English)
1 reference
Alexander Schulte
1 reference
Katrin Liffers
1 reference
Annegret Kathagen
1 reference
Sabine Riethdorf
1 reference
Svenja Zapf
1 reference
Adrian Merlo
1 reference
Katharina Kolbe
1 reference
Manfred Westphal
1 reference
Katrin Lamszus
1 reference
21 July 2013
1 reference
1 reference
15
1 reference
10
1 reference
1289-1301
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference